>NM_080040.5 Drosophila melanogaster separation anxiety (san), mRNA
ATAACTTGCGACCTGCAACCCGAACAATCAGGAACAGCTGAGGCGCTTAAAACACATTTTCCTATTACAA
TTTTCGGCGCAAAGCGCGTTGCTAAATCAACAGAAATCGTACAGACAACATGACTAGGAGCAGCATCGAA
CTGGGCGACGTGACGCCCCACAACATCAAGCAGCTAAAGAAGCTCAACACCGTGGTTTTCCCGGTCTCCT
ACAATGACAAGTTTTACGTGGACGTCCTGGAGGCCGGCGAACTGGCCAAATTGGCCTACTACAACGACAT
TGTAGTGGGCGCCGTCTGTTGTCGCATCGACAACACTGAGAACCAGCGGCGCCTGTATATCATGACCCTA
GGATGCCTCTCCCCGTACCGGCGCCTGGGCATCGGCACAGTTATGTTCGAGCACATTATGAACTTCGCCG
AGAAGGACGGAAACTTCGACAGCATTTTTCTACATGTGCAAATCAACAACAACGGAGCCATCGAGTTCTA
TAAGAAGTTTGGTTTCGAGATTGTTGACACCAAGGAGCAATACTATAAGCGCATCGAGCCGGCGGACGCT
CATGTACTGCAAAAGACTCTGCGCCGCACTGCACCCAACTCAAACAGCACCGCCACCAGCACCACCGCGA
ACTCAAATTCACGTAGTAAAGCACGACAGTTCACATTTGTTTAAAGATGAATTTCAATATGTATAACAAA
CAGACATGTAGAGGCGGCCAAAACGATGTATTCAATTAGTCCGATCATATCTATGTGTAATCAATAATAA
TTACCCCTGCGCGGGAATAAATAGCTCTATACGGCTTG

>AF225902.1 Drosophila melanogaster separation anxiety protein (san) mRNA, complete cds
GATAACTTGCGACCTGCAACCCGAACAATCAGGAACAGCTGAGGCGGTTAAAACACATTTTCCTATTACA
ATTTTCGGCGCAAAGCGCGTTGCTAAATCAACAGAAATCGTACAGACAACATGACTAGGAGCAGCATCGA
ACTGGGCGACGTGACGCCCCACAACATCAAGCAGCTAAAGAAGCTCAACACCGTGGTTTTCCCGGTCTCC
TACAATGACAAGTTTTACGTGGACGTCCTGGAGGCCGGCGAACTGGCCAAATTGGCCTACTACAACGACA
TTGTAGTGGGCGCCGTCTGTTGTCGCATCGACAACACTGAGAACCAGCGGCGCCTGTATATCATGACCCT
GGGATGCCTCTCCCCGTACCGGCGCCTGGGCATCGGCACAGTCATGTTCGAGCACATTATGAACTTCGCC
GAGAAGGACGGAAACTTCGACAGCATTTTTCTACATGTGCAAATCAACAACAACGGAGCCATCGAGTTCT
ATAAGAAGTTTGGTTTCGAGATTGTTGACACCAAGGAGCAATACTATAAGCGCATCGAGCCGGCGGACGC
TCATGTACTGCAAAAGACTCTGCGACGCACTGCACCCAACTCAAACAGCACCGCCACCAGCACCACCGCG
AACTCAAATTCACGTAGTAAAGCACGACAGTTCACATTTGTTTAAAGATGAATTTCAATATGTATAACAA
ACAGACATGTAGAGGCGGCCAAAACGATGTATTCAATTAGTCCGATCATATCTATGTGTAATCAATAATA
ATTACCCCTGCGCGGGAATAAATAGCTCTATACGGCTTGGCCAGTCGAAACTAAAAAAAAAAAAAAAAAA

>XM_018302112.1 Colletotrichum higginsianum IMI 349063 N-acetyl transferase separation anxiety (CH63R_07137), partial mRNA
ATGTCTCTCCCTCAGACCGCGACGATGAAGCCGACACAGTCTTCGATAAAGTCCTTCTTCCAACCTCGCC
AACAACCGTCTTATGCACCCCCGCCGCCGTCGTCAAAGTACGCGCCCGCGCCTCCGACAACTGGAGCTGC
TACTGCTACTGCCCCTCCTCCCGCCGCCAAACCCCCCACCTCGACCACGATAACACCTCCCCCTTCAACA
ACCACGGCATCACCACCGCCGCCGGTGACGACGCCTCCGACACCAGCGGCCTCGATGCCCATCCATCCTA
GTGCCGGCATTCGCCCCGTGGACGACCATGACCTGCAGCCTCTCCGCCGAATAAACTCCCTCCTCCTCCC
AGTCGCCTACCCCGAGACTTTCTACGCCGCCGCCCTTACGGGCCCCCTCTCCCGCGTCATCACCTGGTCC
GACCCGTCCTCCCCCGGTGTGGAGCAGGTCGTCGGTGGCGTCGTCTCCCGCATCGAACCCTCCCCCTTCC
CGCCCGCCTCGCCAGGCGCTCGCCCCGAACACGCCCTTTACATTCAATCCCTAGCCCTCCTCTCCCCCTA
CCGCTCCTACGGCCTCGCGACTGCAGTCATCGATCACCTCGTCGCCGCCGCCGCCGCTTTGTCTCCAGAG
ATCAATCTCCGCCATATCTACGCCCACGTGTGGACGGACAATGAGGAGGGCATGCACTGGTACACTGCAC
GCGGCTTCGAGCGCTACGGGGAGCCACTACAGGGATACTACATCAAGCTGCGCCCCGACTCGGCCTGGAT
CGTCCGCCGCACTGTTGGGCCATTGTCGGTCGGCGCTGGCAGTCGACACACGGAGAAGACGGCTGCGCCC
GTCCCCGGTCCCACCGCAGCTGTTGCAAACCTTCCTCCCATGAGCGGCGGTCCGCCTCGGGCCGCCGACG
AGTCACTCTCAAGAACCCCCTCAGGCCAATCCTTCCAAAACCGCCGAGCCGCCACAGAGTGGAACGACCT
GCCCGAAGACATGGCTTCAAGCATGCTCGCCCCTCCCCGGAACAGCGGCGGCTCAGGTGCAAGCTCAAGG
AGCAGCTCCAGCGTGAGGAAGAAGAGGGACAGATCATACCCCGCTGCGGCGTTCCAGGGGTAG

>OF020206.1 KR 1020200083304-A/6: PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OF ANXIETY DISORDER COMPRISING MAGNOLIA OBOVATA EXTRACT AS AN ACTIVE INGREDIENT
AAGTGCATCATCGTTGTTCATACA

